Unlike in the navtemadlin-treated tumor cell proteome [24], we did not detect MDM2 or p21 in the navtemadlin-treated endothelial proteome by mass spectrometry; the proteins were, however, detected by western analysis (Fig. 1E). The gene discussed is CDKN1A; the disease is neoplasm.